The Psychiatry Group aims to research ways to improve outcomes for people diagnosed with a psychaitric disorder.
Our diversely skilled team achieve this aim with research focuses from genetics, brain imaging, experimental measurements of behaviour through to the implementation of intervention, methods of clinical assessment and study of societal and media attitudes.
We focus on measurement of symptom severity and related treatment effectiveness; efficacy and outcomes related ECT; management of depression with mobile phones; mood measurement through facial recognition and expression; and media portrayal of antidepressant drugs.
We are investigating the nature of emotional expression in northern cultures by applying methods and expertise drawn from clinical psychaitry, the arts, psychology, education, computing, medical and social sciences.
Understanding and performing action is intrinsically linked to social cognition. Our research elicits an understanding of this area in typical populations as well as in autism, cerebral palsy and ADHD by using a range of methods designed to measure action.
We aim to: i) to identify biomarkers of schizophrenia, and ii) to understand decision making in schizophrenia.